SynapseNeurosciencePeer-reviewed journal article
CORTICOTROPIN-RELEASING FACTOR- DOPAMINE INTERACTIONS IN MALE AND FEMALE MACAQUE: BEYOND THE CLASSIC VTA
Abstract
Dopamine (DA) is involved in stress and stress-related illnesses, including many psychiatric disorders. Corticotropin-releasing factor (CRF) plays a role in stress responses and targets the ventral midbrain DA system which is composed of DA and non-DA cells, and divided into specific subregions. Although CRF inputs to the midline A10 nuclei ('classic VTA') are known, in monkeys, CRF-containing terminals are also highly enriched in the expanded A10 parabrachial pigmented nucleus (PBP) and in the A8 retrorubral field subregions. We characterized CRF-labeled synaptic terminals on DA (tyrosine hydroxylase, TH+) and non-DA (TH-) cell types in the PBP and A8 regions using immuno-reactive electron microscopy (EM) in male and female macaques. CRF labeling was present mostly in axon terminals, which mainly contacted TH-negative dendrites in both subregions. Most CRF-positive terminals had inhibitory (symmetric) profiles. In both PBP and A8, CRF symmetric (inhibitory) synapses onto TH-negative dendrites were significantly greater than asymmetric (excitatory) profiles. This overall pattern was similar in males and females, despite shifts in the size of these effects between regions depending on sex. Because stress and gonadal hormone shifts can influence CRF expression, we also did hormonal assays over a 6-month time period, and found little variability in basal cortisol across similarly housed animals at the same age. Together our findings suggest that at baseline, CRF-positive synaptic terminals in the primate PBP and A8 are poised to regulate DA indirectly through synaptic contacts onto non-DA neurons.
- Citations
- 2
- FWCI
- 0.37
- Field percentile
- top 44%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cocaine experience abolishes the motivation suppressing effect of CRF in the ventral midbrain
Idaira Oliva, Melissa Donate, … Matthew J. Wanat·Addiction BiologyPeer-reviewed·Nov 12, 2019
- Subcellular interactions of neuropeptide Y and corticotropin-releasing factor in the central nucleus of the amygdala in the mouse
Himavarsha Yerraguntla, Joy Onyekachi, … Beverly A.S. Reyes·NeurosciencePeer-reviewed·Feb 18, 2026
- Corticotropin-releasing factor neurons of the bed nucleus of the stria terminalis demonstrate sex- and estrous phase-dependent differences in synaptic activity and in their role in anxiety-potentiated startle
Rachel Chudoba, Joanna Dabrowska·bioRxiv·Nov 15, 2024
- Factors of sex and age dictate the regulation of GABAergic activity by corticotropin-releasing factor receptor 1 in the medial sub-nucleus of the central amygdala.
Siara Kate Rouzer, Marvin Rafael Diaz·NeuropharmacologyPeer-reviewed·Mar 18, 2021
- Peripubertal antagonism of corticotropin-releasing factor receptor 1 results in sustained changes in behavioral plasticity and the transcriptomic profile of the amygdala
Julia Martz, Micah A. Shelton, … Amanda C. Kentner·NeurosciencePeer-reviewed·Jan 9, 2025
- Repeated treatment with cocaine or methamphetamine increases CRF2 and decreases astrocytic markers in the ventral tegmental area and substantia nigra
Amanda Lea Sharpe, Marta Trzeciak, … Michael J. Beckstead·bioRxiv·Feb 13, 2019